Urination Disorders
Welcome,         Profile    Billing    Logout  
 37 Companies   62 Products   62 Products   62 Mechanisms of Action   5 Trials   685 News 


«12345678910111213...1314»
  • ||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Enrollment closed, Enrollment change, Trial primary completion date:  Study of Botulinum Toxin Type A (BOTOX (clinicaltrials.gov) -  Feb 20, 2015   
    P=N/A,  N=51, Active, not recruiting, 
    Recruiting --> Active, not recruiting | N=100 --> 51 | Trial primary completion date: Sep 2015 --> Dec 2015
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  uropro: Delivery Method and Risk for Urogenital Prolapse 15-20 Years Later (clinicaltrials.gov) -  Feb 19, 2015   
    P=N/A,  N=1641, Completed, 
    Recruiting --> Active, not recruiting | N=100 --> 51 | Trial primary completion date: Sep 2015 --> Dec 2015 Recruiting --> Completed | N=2200 --> 1641 | Trial primary completion date: Dec 2016 --> Feb 2014
  • ||||||||||  Trial completion:  Validation of Korean Version of ICIQ-SF (clinicaltrials.gov) -  Feb 13, 2015   
    P=N/A,  N=134, Completed, 
    Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Jun 2014 Active, not recruiting --> Completed
  • ||||||||||  Trial completion:  Lumbar to Sacral Ventral Nerve Re-Routing (clinicaltrials.gov) -  Feb 6, 2015   
    P2,  N=13, Completed, 
    Active, not recruiting --> Completed | N=90 --> 67 | Trial primary completion date: Nov 2014 --> Aug 2014 Active, not recruiting --> Completed
  • ||||||||||  Trial primary completion date:  Combined Spinal Epidural Urinary Retention (clinicaltrials.gov) -  Feb 5, 2015   
    P=N/A,  N=200, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2017
  • ||||||||||  Enrollment open, Trial initiation date, Surgery, Metastases:  Advanced Pelvic Floor Training Program for Prostate Cancer Surgery (clinicaltrials.gov) -  Feb 2, 2015   
    P1/2,  N=88, Recruiting, 
    Trial primary completion date: Dec 2014 --> Dec 2017 Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Jan 2015
  • ||||||||||  Trial initiation date, Trial primary completion date:  Changes in ALPP in Women With SUI Following Air Instillation (clinicaltrials.gov) -  Jan 28, 2015   
    P1/2,  N=10, Not yet recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Jan 2015 Initiation date: Apr 2014 --> Mar 2015 | Trial primary completion date: Dec 2014 --> Dec 2016
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Phase classification, Enrollment change:  Rituximab to Prevent Recurrence of Proteinuria (clinicaltrials.gov) -  Jan 18, 2015   
    P3,  N=60, Recruiting, 
    N=50 --> 8 | Recruiting --> Terminated; Terminated Phase classification: P2/3 --> P3 | N=40 --> 60
  • ||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Trial primary completion date:  Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX (clinicaltrials.gov) -  Jan 17, 2015   
    P=N/A,  N=600, Recruiting, 
    Phase classification: P2/3 --> P3 | N=40 --> 60 Trial primary completion date: Dec 2016 --> Aug 2016
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Prevent Inability To Control Urination (clinicaltrials.gov) -  Jan 13, 2015   
    P3,  N=417, Completed, 
    Active, not recruiting --> Completed | N=612 --> 432 Recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change:  Evaluation of Albuminuria HIV-Infected Patients (clinicaltrials.gov) -  Dec 29, 2014   
    P=N/A,  N=134, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=280 --> 134
  • ||||||||||  Enrollment open:  Feasibility Study Evaluating the ParaPatch System (clinicaltrials.gov) -  Dec 17, 2014   
    P=N/A,  N=60, Recruiting, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
  • ||||||||||  Enrollment change:  Precise Transvaginal Tape Placement Trial (clinicaltrials.gov) -  Nov 23, 2014   
    P=N/A,  N=40, Recruiting, 
    Trial primary completion date: Dec 2013 --> Feb 2015 N=20 --> 40